Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Mihalcioiu · SciRah

Researcher profile · Semantic Scholar

C. Mihalcioiu

Share profile

C. Mihalcioiu — researcher profile on SciRah

h-index: 22
Works: 83
Citations: 7,637

Most-cited papers

Nivolumab in previously untreated melanoma without BRAF mutation.
C. Robert, G. Long, B. Brady, C. Dutriaux +24 more
2015New England Journal of Medicine5,315 citations Open access
Semantic Scholar
Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
Niaz Mahmood, C. Mihalcioiu, S. Rabbani
2018Frontiers in Oncology426 citations Open access
Semantic Scholar
Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial
P. Ascierto, G. Long, C. Robert, B. Brady +24 more
2019JAMA Oncology320 citations Open access
Semantic Scholar
Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma
C. Robert, G. Long, B. Brady, C. Dutriaux +23 more
2020Journal of Clinical Oncology192 citations Open access
Semantic Scholar
Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population.
A. Demers, Z. Nugent, C. Mihalcioiu, M. Wiseman +1 more
2005Journal of American Academy of Dermatology149 citations
Semantic Scholar
Spatially mapping the immune landscape of melanoma using imaging mass cytometry
D. Moldoveanu, L. Ramsay, Mathieu Lajoie, Luke Anderson-Trocmé +37 more
2022Science immunology118 citations
Semantic Scholar
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma With Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination
A. Arance, L. de la Cruz-Merino, T. Petrella, R. Jamal +18 more
2022Journal of Clinical Oncology100 citations
Semantic Scholar
A Unique Morphological Phenotype in Chemoresistant Triple-Negative Breast Cancer Reveals Metabolic Reprogramming and PLIN4 Expression as a Molecular Vulnerability
I. Sirois, A. Aguilar-Mahecha, J. Lafleur, E. Fowler +33 more
2019Molecular Cancer Research100 citations Open access
Semantic Scholar
Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancer
L. Cavallone, A. Aguilar-Mahecha, J. Lafleur, Susie Brousse +16 more
2020Scientific Reports93 citations Open access
Semantic Scholar
A phase 2 study of tremelimumab in patients with advanced uveal melanoma
A. Joshua, J. Monzon, C. Mihalcioiu, D. Hogg +2 more
2015Melanoma research92 citations
Semantic Scholar
Pilot study investigating the prognostic significance of thymidine phosphorylase expression in patients with metastatic breast cancer : a single institution retrospective analysis
Anna Lisa Tedeschi, E. Garoufalis, R. Saleh, A. Omeroglu +4 more
201584 citations
Semantic Scholar
Risk of Second Primary Cancer and Death Following a Diagnosis of Nonmelanoma Skin Cancer
Z. Nugent, A. Demers, M. Wiseman, C. Mihalcioiu +1 more
2005Cancer Epidemiology, Biomarkers and Prevention71 citations Open access
Semantic Scholar
Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant Melanomas
M. Dankner, Mathieu Lajoie, D. Moldoveanu, Tan-Trieu Nguyen +14 more
2018Clinical Cancer Research67 citations Open access
Semantic Scholar
Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma
G. Long, V. Atkinson, P. Ascierto, B. Brady +21 more
2015Journal of Translational Medicine43 citations Open access
Semantic Scholar
DNA methylation signatures of breast cancer in peripheral T-cells
Surabhi Parashar, D. Cheishvili, Niaz Mahmood, A. Arakelian +6 more
2018BMC Cancer39 citations Open access
Semantic Scholar
A phase II, open label, monotherapy study of liposomal doxorubicin in patients with metastatic malignant melanoma
M. Smylie, R. Wong, C. Mihalcioiu, Christopher W. Lee +1 more
2006Investigational new drugs39 citations
Semantic Scholar
Detection methods of circulating tumor cells in cutaneous melanoma: a systematic review.
Stefan Rodic, C. Mihalcioiu, R. Saleh
2014Critical reviews in oncology/hematology38 citations
Semantic Scholar
Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab
J.-M.-G. Tsui, C. Mihalcioiu, F. Cury
2018Cureus33 citations Open access
Semantic Scholar
A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer
S. Chia, S. Ellard, M. Mates, S. Welch +13 more
2017Breast Cancer Research33 citations Open access
Semantic Scholar
A pilot study using dynamic contrast enhanced-MRI as a response biomarker of the radioprotective effect of memantine in patients receiving whole brain radiotherapy
P. Wong, I. Leppert, D. Roberge, Karim Boudam +5 more
2016OncoTarget31 citations Open access
Semantic Scholar
Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors
M. Tonneau, A. Nolin-Lapalme, S. Kazandjian, Edouard Auclin +22 more
2022Oncoimmunology28 citations Open access
Semantic Scholar
A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation
R. Yaeger, M. McKean, R. Haq, J. T. Beck +27 more
2024Cancer Discovery24 citations Open access
Semantic Scholar
Enhanced Anticancer Effect of a Combination of S-adenosylmethionine (SAM) and Immune Checkpoint Inhibitor (ICPi) in a Syngeneic Mouse Model of Advanced Melanoma
Ali Mehdi, M. Attias, Niaz Mahmood, A. Arakelian +4 more
2020Frontiers in Oncology22 citations Open access
Semantic Scholar
The identification of challenges in tissue collection for biomarker studies: the Q-CROC-03 neoadjuvant breast cancer translational trial experience
A. Aguilar-Mahecha, J. Lafleur, M. Pelmus, C. Séguin +11 more
2017Modern Pathology21 citations Open access
Semantic Scholar
Pilot study investigating the prognostic significance of thymidine phosphorylase expression in patients with metastatic breast cancer: a single institution retrospective analysis
Anna Lisa Tedeschi, Z. Eslami, E. Garoufalis, R. Saleh +5 more
2015OncoTargets and Therapy19 citations Open access
Semantic Scholar
Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence
C. Slingluff, K. Lewis, R. Andtbacka, J. Hyngstrom +41 more
2021Journal for ImmunoTherapy of Cancer17 citations Open access
Semantic Scholar
Final efficacy results of NCIC CTG IND.202: A randomized phase II study of recombinant interleukin-21 (rIL21) in patients with recurrent or metastatic melanoma (MM).
T. Petrella, C. Mihalcioiu, E. Mcwhirter, K. Bélanger +11 more
201316 citations
Semantic Scholar
The NF1 tumor suppressor regulates PD-L1 and immune evasion in melanoma.
Diana Berry, D. Moldoveanu, Shivshankari Rajkumar, Mathieu Lajoie +26 more
2025Cell Reports12 citations Open access
Semantic Scholar
Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5′-DFUR, the bioactive metabolite of Xeloda®
Maria ait-Tihyaty, Z. Rachid, C. Mihalcioiu, B. Jean-Claude
2012Breast Cancer Research and Treatment11 citations
Semantic Scholar
A phase I study of gemcitabine/cisplatin/etoposide in the treatment of small-cell lung cancer.
C. Earle, D. Stewart, Y. Cormier, W. K. Evans +3 more
1998Lung Cancer11 citations
Semantic Scholar
Abstract CT258: Phase II trial of fecal microbiota transplantation in combination with ipilimumab and nivolumab in patients with advanced cutaneous melanoma (FMT-LUMINate trial)
Sreya Duttagupta, Meriem Messaoudene, R. Jamal, C. Mihalcioiu +13 more
2024Cancer Research10 citations
Semantic Scholar
Parathyroid Hormone‐Related Protein Inhibition Blocks Triple‐Negative Breast Cancer Expansion in Bone Through Epithelial to Mesenchymal Transition Reversal
Jia-Rong Li, A. Camirand, M. Zakikhani, K. Sellin +4 more
2021JBMR Plus9 citations Open access
Semantic Scholar
799 Durable responses and immune activation with intratumoral electroporation of pIL-12 plus pembrolizumab in actively progressing anti-PD-1 refractory advanced melanoma: KEYNOTE 695 interim data
P. Fernández-Peñas, M. Carlino, K. Tsai, V. Atkinson +35 more
20209 citations Open access
Semantic Scholar
Improved platform for breast cancer circulating tumor cell enrichment and characterization with next-generation sequencing technology.
C. Mihalcioiu, Jia-Rong Li, D. Badescu, A. Camirand +8 more
2023American Journal of Cancer Research8 citations
Semantic Scholar
Decreased progenitor TCF1 + T-cells correlate with COVID-19 disease severity
T. H. Tu, A. Grunbaum, F. Santinon, A. Kazanova +4 more
2024Communications Biology6 citations Open access
Semantic Scholar
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative.
Tess Aalto, M. Abacan, S. Abadi, F. Aghababazadeh +496 more
2025Cancer Cell5 citations
Semantic Scholar
Characterization of Alistipes montrealensis sp. nov., Isolated from Human Feces of a Patient with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors
B. Routy, C. Richard, M. Benlaïfaoui, S. Lapierre +10 more
2022Microbiology Research5 citations Open access
Semantic Scholar
Impact of the 21-Gene Recurrence Score Assay on Treatment Decisions and Cost in Patients with Node-Positive Breast Cancer: A Multicenter Study in Quebec
S. Hassan, R. Younan, E. Patocskai, L. Provencher +8 more
2022The Oncologist4 citations Open access
Semantic Scholar
The epiMelanoma test enables plasma-based detection of melanoma and prediction of immunotherapy response
O. Dumas, Nicholas Rozza, D. Cheishvili, S. Luk +6 more
2025Scientific Reports3 citations Open access
Semantic Scholar
A phase II study of gefitinib (G) versus carboplatin and gemcitabine (CG) in chemotherapy-naïve patients with advanced non-small cell lung cancer (NSCLC) and ECOG performance status (PS) 2.
S. Agarwal, V. Hirsh, J. Agulnik, V. Cohen +2 more
20103 citations
Semantic Scholar
Phase II study of concurrent temozolomide and whole brain radiation therapy in patients with brain metastasis.
S. Dawood, J. Ragaz, S. Navaratnam, C. Mihalcioiu
2006Journal of Clinical Oncology3 citations
Semantic Scholar
142P Infusion time of adjuvant PD-1 therapy in high-risk resectable melanoma: Accounting for distance from clinic, scheduling changes over time, and appropriately adjusting p-values in SWOG S1404
S. Patel, K. Kendra, K. Grossmann, E. Buchbinder +14 more
2025Immuno-Oncology and Technology2 citations Open access
Semantic Scholar
Abstract 3524: Role of the gut microbiota in the development of immune-mediated diarrhea and colitis induced by immune checkpoint inhibitors
K. Diop, B. Myriam, Wiam Belkaïd, A. Nolin-Lapalme +11 more
2022Cancer Research2 citations
Semantic Scholar
383 Durable responses with intratumoral electroporation of plasmid interleukin 12 plus pembrolizumab in patients with advanced melanoma progressing on an anti-PD-1 antibody: updated data from keynote 695
P. Fernández-Peñas, M. Carlino, K. Tsai, V. Atkinson +30 more
2021Journal for ImmunoTherapy of Cancer2 citations Open access
Semantic Scholar
Utilization of real-world data to assess the effectiveness of immune checkpoint inhibitors (ICIs) in elderly patients with metastatic melanoma
D. Ernst, H. McConkey, L. Liu, M. Butler +9 more
2019Annals of Oncology2 citations Open access
Semantic Scholar
A phase Ib study of an anti-HER2 inhibitor, lapatinib, in combination with a c-MET and VEGFR inhibitor, foretinib, in HER2-positive metastatic breast cancer (MBC): Results from NCIC CTG IND.198.
S. Chia, S. Ellard, M. Mates, S. Welch +9 more
20132 citations
Semantic Scholar
Phase Ib study of sorafenib and vinorelbine as first-line treatment in patients with metastatic breast cancer.
C. Ferrario, Helen Charamis, S. Oyewole-Eletu, C. Mihalcioiu +4 more
20102 citations
Semantic Scholar
Abstract 4657: Investigating the role of circulating bone cells in melanoma patients on immune checkpoint inhibitor therapy
Nicholas Rozza, C. Mihalcioiu, Richard Kremer
2025Cancer Research1 citations
Semantic Scholar
A pilot study of the neoadjuvant use of vemurafenib plus cobimetinib in patients with BRAF-mutant melanoma with palpable lymph node metastases: Survival results.
T. Petrella, C. Mihalcioiu, C. Nessim, A. Spatz +2 more
2023Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Abstract P6-01-39: The impact of the 21-gene Recurrence Score® assay upon physician treatment recommendations in the neoadjuvant setting in lymph node-negative breast cancer patients in a multicenter prospective study in Quebec
M. Yordanova, L. Sidéris, P. Dubé, J. Boileau +8 more
2023Cancer Research1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

V. Atkinson×7
Invite
V. Atkinson — researcher profile on SciRah
G. Long×5
Invite
G. Long — researcher profile on SciRah
R. Jamal×5
Invite
R. Jamal — researcher profile on SciRah
Ian R. Watson×5
Invite
Ian R. Watson — researcher profile on SciRah

×5

Invite

A. Robidoux — researcher profile on SciRah

Invite

A. Elkrief — researcher profile on SciRah

Invite

C. Robert — researcher profile on SciRah

Invite

B. Brady — researcher profile on SciRah

Invite

C. Dutriaux — researcher profile on SciRah

Invite

L. Mortier — researcher profile on SciRah

Invite

J. Hassel — researcher profile on SciRah

P. Rutkowski×4

Invite

P. Rutkowski — researcher profile on SciRah